Meridix Labs
Perimenopause

Perimenopause symptoms in your 40s

Perimenopause is the multi-year hormonal transition that ends in menopause. It can start as early as the late 30s and most often begins in the early-to-mid 40s. It is the single most under-recognized hormonal picture in women's medicine, and the women going through it are routinely told they are stressed, anxious, or imagining it.

In short

Perimenopause is defined by hormonal chaos, not deficiency. Estradiol swings high and low; progesterone drops first; FSH rises in fits and starts. A single hormone draw in a perimenopausal woman often looks normal even when she is symptomatic. The symptom picture matters more than the labs.

When perimenopause starts

Median age of menopause (12 months without a period) in the United States is 51. Perimenopause — the run-up — typically lasts 4 to 8 years. That means most women begin perimenopause in their early-to-mid 40s, and a meaningful number begin in their late 30s.

"You're too young for perimenopause" is one of the most common things women in their 40s are told. It is rarely correct.

The full symptom picture (not just hot flashes)

Hot flashes get the headline, but they are not the most common early symptom. The fuller picture includes:

  • Cycle changes — shorter cycles first (often 21–25 days), then more variable, then occasional skipped months. Heavier bleeding is common because anovulatory cycles lack the progesterone that opposes estrogen-driven endometrial growth.
  • Sleep disruption — often the first symptom. Waking at 3 a.m., unable to fall back asleep. Sleep often degrades months or years before any hot flash.
  • Mood and anxiety changes — new-onset or worsened anxiety, low mood, irritability, rage. Often dismissed as life stress; often hormonal.
  • Cognitive fog — word-finding issues, forgetfulness, feeling "off." Improves after menopause in most women.
  • Joint aches — generalized stiffness, often worse in the morning. Frequently misattributed to age or arthritis.
  • Vasomotor symptoms — hot flashes, night sweats. These typically come later in perimenopause.
  • Vaginal dryness and painful intercourse — from declining estradiol's effect on vulvovaginal tissue.
  • Migraines, especially menstrual migraines — often worsen in perimenopause then improve at menopause.
  • Heart palpitations — typically benign but worth ruling out other causes.
  • Weight redistribution — especially visceral weight gain even without dietary change.
  • Libido changes — usually downward, sometimes upward in early perimenopause from estrogen surges.

Why the labs often look 'normal'

Most clinicians order a TSH, an FSH, an estradiol, and call it done. The problem: in perimenopause, hormones swing wildly day to day and cycle to cycle. A single draw catches a single moment.

FSH rises in perimenopause but the rise is not steady. A perimenopausal woman can have an FSH of 8 mIU/mL one month (well within "premenopausal range") and 40 mIU/mL the next. A single normal FSH does not rule out perimenopause.

Estradiol often runs higher than premenopausal averages early in perimenopause and only falls late. A normal or even elevated estradiol does not rule out perimenopause.

Progesterone drops first because anovulatory cycles produce little of it. A low luteal-phase progesterone in a 43-year-old with cycle and mood symptoms is informative — but it requires drawing on day 21-ish, which is rarely done.

The North American Menopause Society and ACOG both state explicitly: perimenopause is a clinical diagnosis. A symptom picture in a woman in her 40s with cycle changes is enough. Lab confirmation is not required to start treatment.

What helps

This is a category where treatment options are real and effective. We don't prescribe here — that conversation belongs with your clinician — but knowing the landscape helps you ask the right questions.

  • Hormone therapy. For most women under 60 within 10 years of menopause, the benefit-risk profile of menopausal hormone therapy is favorable per current NAMS and ACOG guidance. It is the most effective treatment for vasomotor symptoms, sleep, and vulvovaginal symptoms, and has bone-health benefits. Discuss with a clinician who is current on the data — many practicing clinicians still operate on outdated Women's Health Initiative interpretations from 20+ years ago.
  • Non-hormonal options. Several non-hormonal medications are FDA-approved or commonly used for vasomotor symptoms; cognitive behavioral therapy is effective for insomnia; topical vaginal estrogen has minimal systemic absorption and is safe for most women including many with a breast-cancer history.
  • Lifestyle. Strength training is genuinely important — for bone, metabolism, mood. Sleep hygiene, alcohol moderation, and stress management have moderate effects.
  • Mental health. If anxiety or depression are prominent, addressing them directly is appropriate — they are not less real because they are hormonally driven.
What doctors often miss

The dismissal patterns worth knowing about.

"You're too young for perimenopause." Median onset is early-to-mid 40s, and a meaningful number of women begin in their late 30s. The dismissal of women in their early 40s is the most common pattern.

"Your labs are normal." Perimenopause is a clinical diagnosis. A single normal FSH or estradiol does not rule it out. NAMS and ACOG explicitly state that lab confirmation is not required to start treatment when the clinical picture fits.

Treating anxiety and insomnia in isolation when the picture is hormonal. An SSRI for new-onset anxiety in a 44-year-old whose cycles have shortened and who's waking at 3 a.m. is not wrong — but missing that the underlying driver may be perimenopause means missing the broader treatment options that would address the full picture.

Out-of-date views on hormone therapy. Twenty years after the Women's Health Initiative, many primary care clinicians still operate from misread headlines. The current NAMS position is that for healthy symptomatic women under 60 or within 10 years of menopause, the benefit-risk profile of MHT is favorable. If you've been told blanket no, ask for a referral to a NAMS-certified provider.

Questions to bring to your doctor

  1. 1Given my age, cycle changes, and the symptoms I'm describing, are we considering perimenopause as part of the picture?
  2. 2If labs come back 'normal,' how do we interpret that given how variable hormone levels are in perimenopause?
  3. 3What's your view on menopausal hormone therapy for women in their 40s with my profile? If you're not the right person to discuss this, can you refer me to someone who specializes in menopause?
  4. 4Could a luteal-phase (day 21-ish) progesterone tell us anything useful given my cycle pattern?
  5. 5Are there things I should be doing now — strength training, bone-density baseline, cardiovascular screening — that get more important as I move through this transition?

Frequently asked

Can perimenopause start in my 30s?
Yes. About 5% of women enter perimenopause before 40. Below 40 is sometimes called early perimenopause; below 40 with full menopause is premature ovarian insufficiency, which has additional implications (bone, cardiovascular, fertility) and deserves a workup.
How long does perimenopause last?
Typically 4 to 8 years, sometimes longer. The transition ends 12 months after the final menstrual period — that 12-month mark is when menopause is officially defined.
Why are my periods heavier in perimenopause?
Anovulatory cycles (cycles without ovulation) become more common. Without ovulation there's no corpus luteum, so progesterone is low. Estrogen continues to build the endometrium without progesterone to balance it, leading to heavier shedding. Persistent heavy bleeding still warrants an evaluation — fibroids, polyps, and endometrial hyperplasia are real causes that need to be ruled out.
Is HRT safe?
For healthy symptomatic women under 60 or within 10 years of menopause, the current guidance (NAMS, ACOG, Endocrine Society) is that the benefit-risk profile of hormone therapy is favorable. Risks rise with age at initiation, certain types and doses, and certain personal-history factors. The conversation belongs with a clinician current on the data — ideally a NAMS-certified provider.

Want a personalized read on your situation?

The Women's Health Companion gives you a cycle-day-aware interpretation of your hormone labs, symptom-pattern guidance, or trimester-aware pregnancy support — calibrated, not dismissive.

Open the companion

Related reads

This article is for education only. It is not a substitute for an OB/GYN, reproductive endocrinologist, midwife, or your own clinician. If something feels wrong, trust that and seek care.